• Aucun résultat trouvé

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression

N/A
N/A
Protected

Academic year: 2021

Partager "Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-00663872

https://www.hal.inserm.fr/inserm-00663872

Submitted on 27 Jan 2012

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Polymorphisms in the interleukin 4, interleukin 13 and

corresponding receptor genes are not associated with

Systemic Sclerosis and do not influence gene expression

Jca Broen, Philippe Dieude, M Vonk, L Beretta, B Rueda, A Herrick, J

Worthington, N Hunzelmann, G Riemekasten, H Kiener, et al.

To cite this version:

Jca Broen, Philippe Dieude, M Vonk, L Beretta, B Rueda, et al.. Polymorphisms in the interleukin

4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do

not influence gene expression. 5th European Workshop on Immune-Mediated Inflammatory Diseases,

Dec 2010, Sitges-Barcelona, Spain. pp.P47, �10.1186/1479-5876-8-S1-P47�. �inserm-00663872�

(2)

P O S T E R P R E S E N T A T I O N

Open Access

Polymorphisms in the interleukin 4, interleukin 13

and corresponding receptor genes are not

associated with Systemic Sclerosis and do not

influence gene expression

JCA Broen

1*

, P Dieude

2

, M C Vonk

1

, L Beretta

3

, B Rueda

4

, A Herrick

5

, J Worthington

5

, N Hunzelmann

6

,

G Riemekasten

7

, H Kiener

8

, R Scorza

3

, C P Simeon

9

, V Fonollosa

9

, P Carreira

10

, N Ortego-Centeno

11

,

M A Gonzalez-Gay

12

, P Airò

13

, MJH Coenen

14

, A Aliprantis

15

, J Martin

4†

, Y Allanore

16†

, TRDJ Radstake

1†

From 5th European Workshop on Immune-Mediated Inflammatory Diseases

Sitges-Barcelona, Spain. 1-3 December 2010

Aim

Polymorphisms in the interleukin 4 (IL4), interleukin 13

(IL13) and their corresponding receptors have previously

been found associated with systemic sclerosis (SSc). In

this study we aim to validate these previous observations

and scrutinize their effects on gene expression.

Patients and methods

We genotyped a cohort consisting of 1902 systemic

sclero-sis patients and 1503 healthy controls, derived from

France, The Netherlands, Spain, United Kingdom, Italy

and Germany. Taqman assays were used for genotyping

three SNPs correlating with IL-4 and receptor; interleukin

4 alpha receptor Q576R (rs1801275), interleukin 4 RI75V

(rs1805010), and

−590C/T (rs2243250). In the Il-13 gene

the following SNPs were genotyped; R130Q (rs20541),

(-1112C/T), rs1800925 and rs6646259 (base 43163:G/A).

In addition, we investigated the effect of these

polymorph-isms on corresponding gene expression with RT-PCR in B

cells, T cells, plasmacytoid dendritic cells, monocytes and

myeloid dendritic cells.

Results

None of these polymorphisms was found to be enriched in

the SSc population or in any SSc clinical subtype. In

addi-tion, we did not observe an effect on expression levels in

the cell subtypes.

Conclusions

Our data show that these polymorphisms do not play a

role in SSc and do not influence gene expression levels.

Author details

1Dept. of Rheumatology, Radboud University Nijmegen Medical Center, The

Netherlands.2Université Diderot Paris 7, Service de Rhumatologie, Hospital Bichat Claude Bernard, Paris, France.3Referral Center for Systemic Autoimmune

Diseases, University of Milan, Italy.4Instituto de Parasitología y Biomedicina, CSIC, Granada, Spain.5Rheumatic Diseases Centre, University of Manchester,

Salford Royal NHS Foundation Trust, UK.6Dept. of Dermatology, University of Cologne, Germany.7Dept. of Rheumatology and Clinical Immunology, Charité

University Hospital and German Rheumatism Research Centre, a Leibniz institute.8Dept. of Internal Medicine, Division of Rheumatology, University of

Vienna, Austria.9Servicio de Medicina Interna, Hospital Vall d’Hebron, Barcelona,

Spain.10Servicio de Reumatologia, Hospital 12 de Octubre, Madrid, Spain.

11Servicio de Medicina Interna, Hospital Xeral-Calde, Lugo, Spain.12Servicio de

Reumatologia, Hospital Marques de Valdecillas, Santander, Spain.13Servizio di Reumatologia ed Immunologia Clinica, Spedali Civili, Brescia, Italia.14Dept. of

Human Genetics, Radboud University Nijmegen Medical Center, The Netherlands.15Dept. of Immunology and Infectious Diseases, Harvard School of

Public Health, Boston, MA, USA.16Université Paris Descartes, INSERM U781,

Hôpital Necker, Paris, France and Université Paris Descartes, Service de Rhumatologie A, Hôpital Cochin, Paris, France.

Published: 25 November 2010

doi:10.1186/1479-5876-8-S1-P47

Cite this article as: Broen et al.: Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression. Journal of Translational Medicine 2010 8(Suppl 1):P47.

† Contributed equally

1

Dept. of Rheumatology, Radboud University Nijmegen Medical Center, The Netherlands

Full list of author information is available at the end of the article Broen et al. Journal of Translational Medicine 2010, 8(Suppl 1):P47 http://www.translational-medicine.com/content/8/S1/P47

Références

Documents relatifs

Additionally, the associations between SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1 and PXR genotypes and seven clinical and histo-pathological tumor characteristics (estrogen

Bientôt on se retrouvera, et là : la joie, S'adonner à nouveau à de nombreux émois, Nos deux corps enlacés, dans de nouveaux ébats,. Nos deux cœurs enflammés, à la fin

The third part has dealt with the Universal Negro Improvement Association initiated by Marcus Mozia Garvey stood firm in front of various opposing forces, namely the

Pour certains patients l’insuline NPH devra être administrée deux fois par jour afin d’obtenir un contrôle glycémique comparable à celui obtenu avec l’insuline ultralente

Heike Behrens, Karin Madlener and Katrin Skoruppa 1 The role of scaffolding in children’s questions: Implications for (preschool) language assessment from a usage-based

Among the 24 SNPs analyzed in the PRR and the 5′-UTR of the fCD209 gene, no genotype or allele showed a significant association with the outcome of the infection (Additional file 2)..

In addition to these in situ measurements, 26 stainless steel electropolished canis- ters were filled for post-campaign analysis of volatile organic compound (VOC) (ethane,

Our results showed that the heterozygous genotypes TC and AG of the ESR1 PvuII and XbaI polymorphisms were significantly elevated in T2DM patients compared with control individuals (P